Uncategorized

Austria’s new growth fund could further bolster its dynamic biotech innovation economy

Published

on

The national growth vehicle isn’t biotech‑dedicated, but channeling capital toward life sciences would amplify Austria’s strong research hubs, nondilutive funding landscape and reputation as a champion in science and technology.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version